期刊文献+

自体窦房结细胞异位移植治疗缓慢型心律失常的实验研究 被引量:4

Autologous sinoatrial node cells heterotopic transplantation for treating bradycardia:an experiment with dogs
原文传递
导出
摘要 目的探索自体窦房结细胞异位移植,构建心室异位起搏灶治疗缓慢型心律失常的可行性。方法将健康成年犬16只随机分为移植组和对照组(每组8只)。移植组切取窦房结组织并制成细胞悬液后,注射到自体右心室近心尖部心肌内,对照组切取窦房结后,于右心室相同部位注射等量培养液。2周后建立完全性房室传导阻滞动物模型并进行电生理检查。对移植组犬经股静脉注射异丙肾上腺素和阿托品,研究心率变化。免疫荧光染色观察移植的细胞存活状况及其与心室肌细胞形成的缝隙连接结构。结果消化分离成年犬窦房结得到的自主搏动的细胞结构和活性保持良好。建立完全性房室传导阻滞模型1 h 后,移植组犬心率(91±14)次/min 高于对照组(49±11)次/min(t=6.672,P<0.01),且此室性心律起源于细胞移植部位。注射异丙肾上腺素后,移植组室性心率由(95±11)次/min 增加至(118±15)次/min(t=3.497,P<0.01),而注射阿托品后室性心律无明显改变[分别为(95±11)次/min 和(101±17)次/min](t=0.838,P>0.05)。免疫荧光染色法证实,移植的细胞在移植部位存活,且细胞间有缝隙连接蛋白形成。结论成年犬窦房结细胞移植到自体右心室壁,能够提高完全性房室传导阻滞后的心室率,且对异丙肾上腺素反应良好,对阿托品无明显反应。移植的细胞可与周围细胞形成缝隙连接。 Objective To explore the feasibility of autografting sinoatrial nodal cells heterotopic transplantation to construct an ectopia pacemaker for treating bradycardia. Methods Sixteen healthy adult dogs were randomly divided into 2 equal groups: graft group and control group. The sinoatrial node (SAN) of the dogs in the graft group was harvested and digested into cell suspension in vitro, then injected to the autogenic right ventricular wall adjacent to heart apex. Commensurable culture medium was injected to the same position with the dogs in control group. Two week later, all dogs underwent transcatheter ablation of His bundle to create a complete heart block model and an electrophysiology study was carried out. In order to investigate the change of rhythm, isopruterenol and atropine was injected respectively to dogs of the graft group. Two weeks later the dogs were killed with their hearts taken out. Immunofluorescence histochemistry was used to investigate the survival of grafted cells and gap junction formed between grafted cells and ventricular myocytes. Results The isolated cells from SAN retained active and beating. After ablation, the heart rate of the dogs of the graft group was (91 ± 14)bpm, significantly higher than that of the control group, [ (49 ± 11 ) bpm, t = 6. 672, P 〈 0.01 ], and electrocardiography showed that these ventricular rhythms originated from the cell transplant sites. After the injection of isopruterenol the ventricular rate of the graft group was ( 118 ± 15 ) bpm, significantly higher than that before the injection, (95 ± 11 ) bpm, t = 3.491, P 〈 0.01 ), however, after the injection of atropine, the heart rate of the graft group was ( 101 ± 17 ) bpm, not significantly different from that before the injection, [ (95 ± 11 )bpm, t =0. 838,P 〉0.05]. Immunofluorescence staining showed that the grafted autografting sinoatrial nodal cells all survived and thatthere was connexin-43 expression among the cells. Conclusion Transplantation of autologous SAN cells into the right ventricular wall can boost the ventricular rhythm which is sensitive to isoproterenol but not to atropine. Grafted SAN cells can form gap junctions with adjacent myocytes.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第45期3208-3212,共5页 National Medical Journal of China
基金 国家自然科学基金(30672075 30700157)
关键词 窦房结 细胞移植 移植 自体 心动过缓 Sinoatrial node Cell transplantation Transplantation, autologous Bradycardia
  • 相关文献

参考文献10

  • 1Bonatti V, Agnetti A, Squarcia U. Early and late postoperative complete heart block in pediatric patients submitted open-heart surgery for congenital heart disease. Pediatr Med Chir, 1998,20: 181-186.
  • 2Rye HS, Glazer AN. Interaction of dimeric intercalating dyes with single-stranded DNA. Nucleic Acids Res, 1995, 23:1215-1222.
  • 3Ruhparwar A, Tebbenjohanns J, Niehaus M, et al. Transplanted fetal cardiomyocytes as cardiac pacemaker. Eur J Cardiothorac Surg, 2002, 21:853-857.
  • 4Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation, 2005, 111:11-20.
  • 5Kolossov E, Lu Z, Drobinskaya I, et al. Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes. FASEB J, 2005, 19:577-579.
  • 6Valiunas V, Doronin S, Valiuniene L, et al. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol, 2004, 555:617-626,
  • 7Zhang YM, Hartzell C, Narlow M, et al. Stem cell-derived cardiomyocytes demonstrate an'hythmic potential. Circulation, 2002, 106 : 1294-1299.
  • 8李继文,郭继鸿,张萍,李春,刘元伟,周春燕.腺病毒介导超极化激活环核苷酸门控阳离子通道基因亚型4过度表达对乳鼠心肌细胞电生理特性的影响[J].中华医学杂志,2006,86(19):1332-1336. 被引量:2
  • 9Potapova I, Plotnikov A, Lu Z, et al. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res, 2004, 94:952-959.
  • 10Rubart M, Pasumarthi KB, Nakajima H, et al. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res, 2003, 92 : 1217 -1224.

二级参考文献14

  • 1雷印胜,张海洲,王来城,郭兰敏,范全心,邹承伟,李红昕,王安彪.串联表达大鼠心肌细胞Kir2·1shRNA载体的构建及其体外效应[J].中华医学杂志,2005,85(41):2910-2915. 被引量:10
  • 2Ludwig A,Zong X,Jeglitsch M,et al.A family of hyperpolarization-activated mammalian cation channels.Nature,1998,393:587-591.
  • 3Baruscotti M,Difrancesco D.Pacemaker channels.Ann NY Acad Sci,2004,1015:111-121.
  • 4Rosen MR,Brink PR,Robinson RB.Genes,stem cells and biological pacemakers.Cardiovasc Res,2004,64:12-23.
  • 5Shi W,Wymore R,Yu H,et al.Distribution and prevalence of hyperpolarization activated cation channel (HCN) mRNA expression in cardiac tissues.Circ Res,2002,85:2e1 -2e6.
  • 6Stieber J,Hofmann F,Ludwig A.Pacemaker channels and sinus node arrhythmia.Trends Cardiovasc Med,2004,14:23-28.
  • 7Stieber J,Herrmann S,Feil S.The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.Proc Natl Acad Sci USA,2003,100:15235-15240.
  • 8Edelberg JM,Aird WC,Rosenberg RD.Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA.J Clin Invest,1998,101:337-343.
  • 9Miake J,Marba'n E,Nuss HB.Gene therapy:biological pacemaker created by gene transfer.Nature,2002,419:132-133.
  • 10Qu J,Plotnikov AN,Danilo P,et al.Expression and function of a biological pacemaker in canine heart.Circulation,2003,107:1106-1109.

共引文献1

同被引文献39

  • 1马金,张存泰,黄深,王国强,全小庆.Use of Rats Mesenchymal Stem Cells Modified with mHCN2 Gene to Create Biologic Pacemakers[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2010,30(4):447-452. 被引量:2
  • 2张学锋,马树人,曹加淮,蒙涛,田晓沂.永久起搏器植入术后并发症发生原因及处理[J].心脑血管病防治,2006,6(6):376-378. 被引量:5
  • 3张浩,徐志云,宋智钢,邹毅清,宗刚军.心耳肌细胞移植治疗心脏传导阻滞的研究[J].中华实验外科杂志,2007,24(3):360-360. 被引量:2
  • 4张浩,徐志云,段炼,宋智钢,邹毅清,宗刚军.自体窦房结细胞移植治疗心脏传导阻滞的初步研究[J].第二军医大学学报,2007,28(3):233-236. 被引量:4
  • 5Song Z, Zhong L, Tong S, et al. Primary culture and identification of sinoatrial node cells from newborn rat. Chin Med J (Engl), 2003, 116(3): 465-468.
  • 6Ruhparwar A, Tebbenjohanns J, Niehaus M, et al. Transplanted fetal cardiomyocytes as cardiac pacemaker. Eur J Cardiothorac Surg, 2002, 21(5): 853-857.
  • 7Shiraishi I, Takamatsu T, Minamikawa T, et al. Quantitative histological analysis of the human sinoatrial node during growth and aging. Circulation, 1992, 85(6): 2176-2184.
  • 8Sutyagin PV, Kalinina EE, Pylaev AS. Morphofunctional organization of sinoatrial node in rat heart. Bull Exp Biol Med, 2005, 139(2): 256-259.
  • 9Opthof T, de Jonge B, Masson-Pevet M, et al. Functional and morphological organization of the cat sinoatrial node. J Mol Cell Cardiol, 1986, 18(10): 1015-1031.
  • 10Opthof T, de Jonge B, Jongsma HJ, et al. Functional morphology of the pig sinoatrial node. J Mol Cell Cardiol, 1987, 19(12): 1221-1236.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部